A VP2 in FIG at a bulge bracket calls me. Forty billion in deal volume on his sheet. Stacked resume. Top school, top group, top bank. He wants to move to generalist M&A at a peer shop.
He can’t get a callback.
Not from the banks. Not from the headhunters who were blowing up his phone eighteen months ago. Nothing.
This is the puzzle every specialist banker eventually runs into: why does a banker with more reps than their generalist peers look less qualified when they try to switch lanes? And more importantly — how do you tell, early enough to do something about it, whether you’re in that trap yourself?
This piece is about lane changes inside investment banking. Group-to-group, product-to-product, bank-to-bank. It’s not a guide to breaking in from consulting, Big 4, or corporate finance — that’s a different problem with a different playbook. This is for bankers already in a seat who are trying to figure out whether they’re in the right one, and what it would take to change that.
There are three questions that matter, and most bankers answer them in the wrong order.
Am I actually pigeonholed? Is it too late to move? If I move, what am I willing to give up?
Let’s take them in sequence.
Part I: Diagnosis — Are You Actually Pigeonholed?
Most juniors think they’re pigeonholed long before they are. Most seniors refuse to admit they’re pigeonholed long after they are. Both mistakes cost years.
The signals that your group has actually become your identity in the market:
- Headhunter calls dry up, or narrow to the same vertical every time
- When recruiters do pitch you, it’s always sector-specific seats
- MDs at other banks stop returning intros from your network
- The buy-side funds reaching out are all sector-dedicated
- Your own MDs start referring to you as “the FIG guy” or “the Energy guy” in front of clients
If you’re seeing three or more of these, the market has made a call on you. If you’re seeing none of them, you’re probably not as stuck as you think.
The level you’re at matters as much as the group you’re in. Here’s how the window closes:
Analyst 1–2. You are not pigeonholed. You think you are because a recruiter told you your group was “too niche,” but the resume is too short for the specialization to have calcified. Moves at this level happen all the time and nobody cares.
Analyst 3 / Associate 1. The window is open but closing. This is the decision year. If you’re going to switch, this is when it’s cheapest.
Associate 2–3. Recoverable, but only with a reset — class year, tier, or both. A straight lateral at level into a different group is rare at this stage unless the groups are genuinely adjacent.
VP1. Possible, but expensive. The pitch has to be surgical. Banks underwrite VPs as people who can execute, not as people who need retraining. If your reps don’t translate, the math stops working.
VP2–3. The market has made its call. Fighting it usually costs more than leaning in. Not always — but usually.
The diagnostic question to ask yourself: if a recruiter pitched your dream generalist seat tomorrow, would the MD on the other side see your resume as “interesting background” or as “retraining risk”?
That answer tells you which column you’re in.
Part II: The Specialization Trap — Why FIG, Energy, and Real Estate Are the Hardest Groups to Leave
There’s an unspoken premise behind most sell-side M&A hiring: a deal is a deal is a deal. Coverage groups that trade in standard LBO math, standard DCFs, and standard accretion/dilution models feed the generalist pool seamlessly. Consumer, industrials, TMT, healthcare services — the reps port. The vocabulary is the same. The modeling is the same. An analyst who ran a sell-side in industrials can walk into a consumer group on Monday and be productive by Wednesday.
Three groups break this premise. And if you’re in one of them, you need to understand why the market reads your resume the way it does.
FIG is its own language. Regulatory capital — CET1, Tier 1, risk-weighted assets — is the core valuation driver for banks, and nothing generalists ever touch. Insurance accounting runs on embedded value, statutory versus GAAP reserves, and reserve adequacy tests that look nothing like a standard three-statement model. Bank M&A is underwritten on tangible book value per share accretion, not EPS accretion. When an M&A MD looks at a FIG resume, the real concern isn’t whether you’re smart — it’s whether you can build a consumer LBO from a blank page without Googling it.
Energy doesn’t travel. Reserve-based lending, the PDP/PUD/PROB stack, NAV modeling, type curves — a DCF on an E&P asset doesn’t look like a DCF on anything else. Midstream MLP structures and IDR math are a sector unto themselves. And the commodity overlay changes the entire framework: Energy bankers think in price decks where other bankers think in growth rates. Even Energy M&A reps get discounted outside the sector.
Real Estate is a world apart. NAV and cap rates are the primary valuation currency, not EBITDA multiples. REIT concepts — AFFO, same-store NOI, 1031 exchanges, UPREIT structures — don’t exist anywhere else in the bank. Property-level underwriting isn’t corporate M&A underwriting. And the sector prefers its own: REPE hires from REIB, not from generalist M&A, which means even the natural buy-side exit reinforces the specialization.
Here’s the part that matters. When an M&A MD reads your specialist resume, here’s what actually happens:
The logos look great. The deal sizes are impressive. But the modeling vocabulary is foreign. And the fear — stated or not — is retraining cost. Six months of dead weight while you learn the standard LBO mechanics their Associate 1s built in week three of training. They’d rather hire a less-experienced generalist who plugs in on Monday than a more-experienced specialist who plugs in next quarter.
That’s the trap. More reps, worse resume.
Part III: The Translation Matrix — Which IB-to-IB Switches Actually Work
Not every specialization is a trap, and not every lane change is equally hard. Here’s how the market actually reads the options.
The moves that port cleanly. Recruiters don’t blink at these:
- Consumer ↔ Retail
- Industrials ↔ Chemicals ↔ Aerospace & Defense
- TMT internal moves (software to internet, hardware to semis)
- Healthcare services ↔ generalist M&A
- LevFin → Restructuring — the credit lens, capital structure fluency, and sponsor relationships translate directly. One of the few product-to-product moves the Street actively endorses.
- M&A generalist → any coverage group
The IB-to-IB moves that sound adjacent but aren’t:
- Sponsors ↔ M&A, in either direction. Sponsors runs financings, relationship coverage, and process management. M&A groups want sell-side execution reps and technical depth. The logos overlap, the work doesn’t, and both sides of this switch get discounted.
- FIG → anything outside FIG. Even insurance and banks don’t translate to each other cleanly.
- Energy → industrials. The commodity overlay doesn’t travel.
- Real Estate → gaming/lodging. Sounds close, isn’t.
- LevFin → M&A. Product-to-coverage asymmetry — note this is the opposite outcome from LevFin → RX, because M&A wants sell-side reps while RX wants credit reps.
- ECM/DCM → M&A. The financing rep problem, same as LevFin.
The asymmetry rule: product-to-coverage is harder than coverage-to-product. Coverage-to-coverage within a cluster is easy. Specialist-to-generalist is always the heaviest lift. And product-to-product only works when the underlying rep — credit analysis, capital structure, modeling vocabulary — actually carries over. That’s why LevFin → RX works and LevFin → M&A doesn’t.
The two-step. When the direct move is closed, the indirect move is often open. FIG → generalist MM → bulge bracket M&A. Energy IB → sponsors group → PE. Sponsors → LevFin → RX. Each individual step looks logical to the market even when the end state wouldn’t have been reachable directly. The two-step takes longer, but for anyone past Associate 1 in a sticky group, it’s often the only realistic route.
Part IV: The Flexibility Conversation
This is where most bankers lose the plot. They diagnose correctly. They pick a reasonable target group. And then they refuse the tradeoffs that would actually make the move happen.
Here’s the conversation nobody wants to have.
Taking a year back. Accepting an AS1 seat at a different bank or group after an AS2 year in your current one. It stings. It sounds like failure. It isn’t. It’s an intra-IB reset — you’re staying in banking, keeping your momentum, and trading one year of title for a group that actually positions you for where you want to end up.
Negotiate the offset. Signing bonuses, accelerated promotion timelines, guaranteed bonus for year one — all of this is on the table if you ask. The banks know what they’re asking you to give up and they have levers to make it work.
Pitch it right. “I’m resetting to build the right foundation” is a story. “They made me take a step back” is not. Your narrative matters more than the title change.
And here’s the honest part: two years later, nobody cares. Nobody looks at your resume in 2028 and notices the class year reset in 2026. By then your new group is your story, and the reset is a footnote you don’t even mention.
Dropping a tier. Going from bulge bracket to boutique, or EB to MM, to fix a group problem.
Juniors overweight pedigree and underweight optionality. A move down the league table can be the fastest way out of a dead group. Sponsor coverage at a mid-market shop. A generalist seat at a regional boutique. These function as reset buttons — you trade the logo for a seat that actually lets you build the reps you need.
The honest read on what the buy-side thinks about this later: they care about your last 24 months, not your first 24. If your current 24 months are making you unhireable anywhere, the pedigree you’re protecting isn’t worth what you think it is.
The combined move. Sometimes the only switch that works requires both — a year back and a tier drop. Painful in the moment. Rational in the five-year frame.
This is the conversation that separates bankers who actually change trajectory from bankers who talk about changing trajectory for three years and then don’t.
Part V: When to Lean In Instead
Here’s the part nobody wants to write, because it sounds like giving up.
It isn’t.
Leaning in is the right call when:
- You’re past VP1 in a specialist group and the market has already tagged you
- Your group is actually strong and the exits are real — sector PE, corp dev at a strategic, sector-focused credit
- The switch you’re chasing would require a two-tier drop and a two-year reset to land in a seat that isn’t meaningfully better than a good MD run in your current group
- You’re fighting the specialization because of ego rather than economics
The specialization that feels like a trap at Associate 2 is often the moat at MD. FIG VPs who make MD in FIG are paid like MDs anywhere else. Energy bankers who own the sector through a cycle become indispensable when the sector turns. Real Estate bankers who stay own the relationships when the capital comes back.
The economics of leaning in are often better than the economics of switching. The hard part is recognizing that at VP2 instead of VP5.
The Bottom Line
The worst outcome isn’t switching groups. It isn’t staying in them either. It’s spending three years half-committed to both — one foot in your current group, one foot in a switch that never materializes, and a resume that tells the market you couldn’t decide.
Diagnose honestly. Move early if you’re going to move. Accept the reset if the move requires one. Lean in hard if the math says to stay.
The bankers who thrive inside investment banking are the ones who pick a lane by VP1 and run.
Everyone else is still deciding.